·
13 MIN READ

The latest FDA naloxone approvals and Overdose Awareness Day with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the current state of the overdose epidemic.

series
Overdose Epidemic
AMA Update Podcast
UPDATED
·
10 MIN READ

AMA Advocacy issue briefs

Download PDFs of issue briefs that summarize key health policy issues by providing concise and digestible content for both relevant stakeholders and those who may know little about the topic.

Federal Advocacy
Person looking at a laptop while writing
·
3 MIN READ

Here’s your one-stop shop to meet new DEA training mandate

DEA-registered physicians are now required to complete the one time, eight-hour training requirement. The AMA has you covered. Learn more.

Overdose Epidemic
2023 Annual Meeting delegates from Kansas and Missouri
·
4 MIN READ

Put naloxone in schools so it can save lives

Opioid overdose-reversing drugs such as naloxone save lives. They should be available in educational settings and public areas, the AMA says.

Overdose Epidemic
·
4 MIN READ

AMA adopts new policies on substance use during second day of Annual Meeting

Policies address opioid crisis and medicinal use of psychedelics.

Press Releases
AMA in Action: Ending the overdose epidemic
UPDATED
·
5 MIN READ

Advocacy in action: Ending the overdose epidemic

Science, evidence and compassion must guide patient care and policy change to end the drug-overdose epidemic.

Overdose Epidemic
Narcan nasal spray
·
4 MIN READ

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 

Overdose Epidemic
·
1 MIN READ

AMA statement on DEA extending telehealth prescription flexibilities

The AMA applauds the DEA extending flexibilities in the prescribing of controlled substances through telehealth visits through Nov. 11, 2023.

Press Releases
·
12 MIN READ

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Overdose Epidemic
AMA Update